MetLife Investment Management’s Candel Therapeutics CADL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$129K	Buy	25,546 +10,319	+68%	+$52.2K	﹤0.01%	2406
2025 Q1	$86K	Buy	15,227 +1,454	+11%	+$8.22K	﹤0.01%	2592
2024 Q4	$120K	Buy	13,773 +1,215	+10%	+$10.5K	﹤0.01%	2535
2024 Q3	$87K	Buy	+12,558	New	+$87K	﹤0.01%	2679